| DEXMEDETOMIDINE | Bioxcel | ||
| EQ 0.12MG BASE,EQ 0.18MG BASE ; Film |
Less Than $1000 mn
|
||
| None | None | ||
|
Less Than 5
|
None | ||
| None | None | ||
| IGALMI is an alpha2-adrenergic receptor agonist indicated in adults for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder. | |||
|
Yes
| |||
| IGALMI | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||||
| *** ** ********** *************** *** *** ********* ** ********* | *** ** ********** *************** *** *** ********* ** ********* | **** ************ ********** *************** *** ******* ** ********* **** | **** ************ ********** *************** *** ******* ** ********* **** | **** ************ ********** *************** *** ******* ** ********* **** | **** ************ ********** *************** *** ******* ** ********* **** | ***-******** *************** ********* ******** | ***-******** *************** ********* ******** | ***-******** *************** ********* ******** | ***-******** *************** ********* ******** | ***-******** *************** ********* ******** | ***-******** *************** ********* ******** | ***-******** *************** ********* ******** | ***-******** *************** ********* ******** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|